GREATER MANCHESTER CANCER PLAN TAMESIDE AND GLOSSOP STOCKTAKE

Transcription

1 Reprt t: HEALTH AND WELLBEING BOARD Date: 21 September 2017 Executive Member / Reprting Officer: Subject: Reprt Summary: Angela Hardman, Directr f Ppulatin Health Giden Smith, Cnsultant in Public Health Medicine GREATER MANCHESTER CANCER PLAN TAMESIDE AND GLOSSOP STOCKTAKE The Greater Manchester Cancer Plan was received by the Health and Wellbeing Bard in March The Tameside and Glssp Cancer Bard, which is led by Tameside and Glssp Integrated Care Fundatin Trust with membership frm the Single Cmmissin, have develped a cmprehensive implementatin plan. A detailed wrking actin plan has been develped by the prject manager t supprt the wrk f the lcal wrking grup, and prgress is reprted t Tameside and Glssp Cancer Bard. Appendix 1 and 2 prvide an update n the current lcal psitin and next steps required t deliver the cntributins required in the lcality specific plan. Recmmendatins: The Health and Wellbeing Bard is asked t : 1. Nte the prgress t date with lcal implementatin f the Greater Manchester Cancer Plan; 2. Endrse the lcal actin summaries utlined in Appendix 1 and Receive further prgress reprts. Links t Health and Wellbeing Strategy: Plicy Implicatins: Financial Implicatins: (Authrised by the Sectin 151 Officer) Legal Implicatins: (Authrised by the Brugh Slicitr) Cancer is the mst cmmn cause f death in Tameside fr males and females, and there are significantly mre deaths than there shuld be given the ppulatin age and gender prfile, s imprving cancer utcmes delivers against all life curse pririties f the Health and Wellbeing Strategy. The Greater Manchester Health and Scial Care Strategic Partnership Bard apprved the Greater Manchester Cancer Plan fr implementatin n 24 February This paper summarises the lcal actins required t realise the ambitins f the Greater Manchester Cancer Plan. There are n direct financial implicatins arising frm the reprt at this stage. Hwever, the financial implicatins within further update reprts n the assciated plan will be cnsidered and reprted accrdingly t Health and Wellbeing Bard members. It is imprtant that decisins regarding resurces are made n an evidence based apprach. This reprt sets ut the evidence f the challenges and hw we tackle imprving cancer utcmes.

2 Risk Management : Access t Infrmatin : The Greater Manchester Cancer Plan cntains a substantial amunt f wrk, much f which requires cntributins frm all parts f the cancer system. The prpsed accuntable cancer netwrk mdel as part f cancer vanguard prgramme requires further substantial Greater Manchester system debate and engagement. Transfrmatin funding will be sught t deliver sme f the signature prpsals in the plan, including lung health check (if pilt successful) and delivery f the recvery package. The actins detailed in this lcal stcktake are extensive, but within the scpe f existing service and clinical develpment and imprvement expectatins. The backgrund papers relating t this reprt can be inspected by cntacting Giden Smith, Cnsultant, Public Health Medicine, by: Telephne: Giden.smith@tameside.gv.uk

3 1.0 INTRODUCTION 1.1 The Greater Manchester Cancer Plan was received by Tameside Health and Wellbeing Bard n the 9 March The Tameside and Glssp Cancer Bard, which is led by Tameside and Glssp Integrated Care Fundatin Trust with membership frm the Single Cmmissin, had develp a cmprehensive implementatin plan. 1.2 The Greater Manchester Plan sets ut the ambitins fr Greater Manchester Cancer, the cancer prgramme f the Greater Manchester Health and Scial Care Partnership. It is set ut in eight dmains reflecting a cmbinatin f the five key areas fr change set ut in Taking Charge and the six key wrkstreams f the natinal cancer strategy. 1.3 Much f the wrk set ut in the plan will be delivered by the current and prpsed Greater Manchester Cancer infrastructure. A substantial part f the plan in 2016/17 and 2017/18 is part f the vanguard innvatin prgramme and funded by NHS England s New Care Mdels Team. 1.4 Greater Manchester Transfrmatin funding will be sught t deliver ther key parts f the prgramme and, if apprpriate, t rll ut successful pilts frm the vanguard innvatin prgramme beynd 2017/ GREATER MANCHESTER CANCER PLAN: ACHIEVING WORLD-CLASS CANCER OUTCOMES: TAKING CHARGE IN GREATER MANCHESTER Visin and key bjectives: 1) We will reduce adult smking rates t 13% by 2020; 2) We will increase ne-year survival t mre than 75% by 2020; 3) We will prevent 1,300 avidable cancer deaths befre 2021; 4) We will ffer class-leading patient experience, cnsistently achieving an average verall rating f 9/10 in the natinal survey frm 2018; 5) We will cnsistently exceed the natinal standard fr starting treatment within 62 days f urgent cancer referral; 6) We will ensure that the Recvery Package is available t all patients reaching cmpletin f treatment by Dmains: There are eight dmains within the Greater Manchester plan; reflecting a cmbinatin f the five key areas fr change set ut in Achieving wrld-class cancer utcmes: Taking charge in Greater Manchester and the six key wrk streams f the Natinal Cancer Strategy.

4 3.0 CANCER IN TAMESIDE AND GLOSSOP 3.1 A detailed summary f lcal cancer experience received by T&G Single Cmmissining Bard in June 2017 is included as appended. 3.2 In 2016 Cancer was the main cause f death in 15.6% f the ppulatin in Tameside and Glssp Clinical Cmmissining Grup (331 ut f 2,119 ttal deaths). 3.3 In Tameside and Glssp Clinical Cmmissining Grup all f the fllwing were higher than the NHSE average: incidence f cancer; mrtality rates; under 75 years f age mrtality; number f deaths frm cancers cnsidered preventable; adult smking rates. 3.4 The majrity f the time we are achieving the peratinal waiting times standards (93% within 2 week waits, 96% within 31 days and 85% within 62 days). 3.5 NHS Right Care data highlights areas fr imprvement where we were wrse than ur average 10 Clinical Cmmissining Grup equivalents including: Screening uptake; Smking; Spend n primary care prescribing; Waiting times fr endscpy; Liver disease. 3.6 The reprt t Single Cmmissining Bard cncludes that the fllwing areas need t be cnsidered as part f an nging imprvement prcess and incrprated int the lcal respnse t cancer: What else can we d t detect Cancer earlier and raise public awareness thrugh natinal and lcal campaigns?

5 Hw d we reduce emergency presentatins (impact n nn-elective admissins)? Rle f Primary Care e.g. Use f e-referrals and EMIS templates. Imprve access e.g. Straight t Test Clnscpy, new lung pathway, bwel prep issued within primary care. Ensure access t services is equitable. Planning, demand and Capacity. - Impact f Lcum staff e.g. new rules IR35. - Hw d we reduce the number f DNAs? - Learning frm breach analysis. - Supprt within the cmmunity. - Data shws Length f Stay in hspital is greater than cmparative CCGs. - Care planning, data shws we nly prepare 32.5% f after care plans - Hw d we imprve patient experience? 4.0 TAMESIDE AND GLOSSOP RESPONSE 4.1 Visin and key bjectives GM Cancer Plan key bjective 1. We will reduce adult smking rates t 13% by We will increase ne-year survival t mre than 75% by We will prevent 1,300 avidable cancer deaths befre We will ffer class-leading patient experience, cnsistently achieving an average verall rating f 9/10 in the natinal survey frm We will cnsistently exceed the natinal standard fr starting treatment within 62 days f urgent cancer referral 6. We will ensure that the Recvery Package is available t all patients reaching cmpletin f treatment by 2019 Tameside and Glssp current psitin Current dwnward trend f up t 2% per year. 22.1% in One year survival frm cancer is imprving year n year but is lwer that the NHSE average (70.2%) at 67.6% in When cmparing t 10 similar CCGS tw were lwer than T&G CCG. 331 cancer deaths in T&G in Aim t avid 130 deaths in T&G by Cancer patient experience rating 8.9 fr T&GICFT and 8.8 fr T&GCCG fr 2016 (England 8.7). Better than the NHSE average (82.2%) fr GP referral t first definitive treatment within 62 days in Q1 16/17. When cmparing t 10 similar CCGS all were lwer. T&G ICFT made a successful bid t Macmillan fr 2 year funding fr a 3 member team t supprt lcal implementatin f the Recvery Package. 4.2 T date the Tameside and Glssp Cancer Bard has: audited lcal wrking psitin and utlined actins required t meet the Lcality Specific actins; Agreed terms f reference and membership f Greater Manchester Cancer Plan lcal wrking grup t further prgress the plan that will meet n a mnthly basis;

6 assigned a Care Tgether Prject Manager wh started t develp a prject plan; prgressed the develpment f the Lcality specific plan; established Task and Finish Grups fr each f the wrk streams identified within the plan t versee the implementatin f Lcality Specific actins with these wrk streams: Preventin and Earlier & Better Diagnsis (lead - Giden Smith) Living With and Beynd Cancer (lead - Carl Diver ) Imprved & Standardised Care (lead Susi Penney) Patient Experience & User Invlvement (lead - David Banks) Cmmissining & Accuntability (lead - Alisn Lewin) Research & Educatin (lead Tameside and Glssp Cancer Bard) 4.2 Ging frward the Tameside and Glssp Cancer Bard will be kept infrmed f prgress by the Steering Grup with any areas f cncern escalated as apprpriate. 4.3 Greater Manchester and Tameside and Glssp gvernance fr Greater Manchester Cancer Plan implementatin: 3.3 A detailed wrking actin plan has been develped by the prject manager t supprt the wrk f the lcal wrking grup, and prgress is reprted t T&G Cancer Bard. 3.4 Appendix 1 and 2 prvide an update n the current lcal psitin and next steps required t deliver the cntributins required in the Lcality specific plan. 4.0 LOCAL HIGHLIGHTS 4.1 Preventin and Earlier and Better Diagnsis 4.2 Tbacc Cntrl: Smking is a significant challenge lcally, but gd prgress is being made with year n year reductins fr adults, yung peple and pregnant wmen. And the Tameside Tbacc Alliance is an effective partnership driving the HWBB Turning the Curve ambitin t reduce lcal smking prevalence.

7 4.3 Cancer Champins Scial Mvement: The GM lead fr this prgramme is Ben Gilchrist, Deputy Chief Executive f Actin Tgether in Tameside and a HWBB member, and this cnnectin prvides additinal impetus t lcal activity. Actin Tgether and Be Well Tameside have previusly wrked tgether n a Macmillan funded prject t recruit and supprt cmmunity vlunteers, and there is strng lcal expertise and cmmitment t enable this visin. 4.4 Prmting Screening: the Bwel Cancer Screening Prgramme fr Tameside, Stckprt & Traffrd includes a shared Health Imprvement Practitiner fr Tameside and Glssp wh leads and crdinates the lcal prmtin f bwel cancer screening. T&G Primary Care Delivery and Imprvement Grup have an Quality Imprvement Initiative fr cancer screening. 4.5 T&G Cancer Early Detectin Netwrk: This grup links lcal stakehlders including: Public Health, Be Well Tameside, Bwel Cancer Screening Team, Cancer Research UK, wrkplace health, Macmillan GP, CCG cmmissiner, Tameside Macmillan Centre and Actin Tgether. It enables crdinatin and jint wrking, and its members will be key t the develpment f the scial mvement, symptm awareness and imprving screening uptake. 4.6 Cancer Waiting Times: Lcal gd perfrmance is built n sustained cncerted effrt f clinical teams t cntinuusly imprve pathways and prtcls. Plans fr further develpments t reduce waits fr cmplex and high vlume pathways in step with GM pathway wrk is in hand lcally. 4.7 Living With and Beynd Cancer 4.8 Recvery Package: T&G ICFT made a successful bid t Macmillan fr 2 year funding fr a 3 member team t supprt lcal implementatin f the Recvery Package. 4.9 Imprved and Standardised Care 4.10 Lymphedema service: T&G has had an award winning service in place fr several years, and is very well placed t extend this in line with GM aspiratin GM Clinical Pathways: T&G cancer patients receive much f their care frm a range f prviders acrss GM, and efficient pathways are critical fr gd utcmes. Lcal clinicians are actively invlved in the develpment and lcal implementatin f these pathways Patient Experience and User Invlvement 4.13 T&G Macmillan Unit: This recently pened facility at Tameside Hspital includes a dedicated team member with a remit fr user and cmmunity engagement, as well as an infrmatin centre. The Unit is very well placed t supprt the develpment f the Recvery Package, patient engagement and Cancer Champin recruitment and supprt. 5.0 LOOKING FORWARD TO By 2021 in Tameside and Glssp, in line with the GM visin we will have: reduced smking in adults, yung peple and pregnant wmen increased ne year survival

8 reduced the number f preventable deaths frm cancer imprved patient experience imprved waiting times intrduced the Recvery Package 5.2 In additin the Tameside and Glssp Cancer Bard will have verseen and crdinated a prgramme f develpments and transfrmatin that addresses the actins fr CCGs and Prvider Trust priritised in the GM Cancer Plan, including: grwth f a GM Cancer Champins Scial Mvement increased uptake f screening expanded lympedema service adptin f standard GM system-wide pathways ptimised multi -disciplinary team prcesses adptin f ptimal GM tumur specific service specificatins 7 day specialist palliative care advice and assessment chice in end f life care shared digital palliative and end f life care recrds patient self-referral stratified fllw pathways f care service user invlvement in cntinuus develpment f services access t clinical nurse specialists integrated acute nclgy service primary care educatin platfrm 6.0 RECOMMENDATIONS 6.1 As detailed n the frnt f this reprt.